| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.46B | 34.43B | 33.69B | 34.17B | 32.78B | 30.77B |
| Gross Profit | 7.97B | 7.87B | 7.37B | 7.53B | 6.76B | 4.99B |
| EBITDA | 3.35B | 3.41B | 3.24B | 4.24B | 4.52B | 1.43B |
| Net Income | 708.00M | 750.00M | 594.00M | 1.45B | 1.65B | -1.15B |
Balance Sheet | ||||||
| Total Assets | 46.82B | 46.09B | 45.71B | 42.95B | 43.57B | 40.66B |
| Cash, Cash Equivalents and Short-Term Investments | 5.52B | 4.92B | 5.42B | 4.35B | 4.83B | 4.06B |
| Total Debt | 14.03B | 14.02B | 12.83B | 12.71B | 12.65B | 14.45B |
| Total Liabilities | 27.27B | 26.45B | 26.31B | 24.57B | 25.96B | 25.34B |
| Stockholders Equity | 15.25B | 15.24B | 14.70B | 14.03B | 13.48B | 11.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -613.00M | 2.45B | 116.00M | 2.44B | 2.89B |
| Operating Cash Flow | 0.00 | 1.80B | 4.18B | 1.01B | 3.36B | 4.21B |
| Investing Cash Flow | 0.00 | -2.76B | -1.74B | -54.00M | -217.00M | -1.30B |
| Financing Cash Flow | 0.00 | 500.00M | -1.65B | -1.57B | -2.65B | -2.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥307.04B | 14.27 | 5.12% | 2.36% | 3.03% | -8.38% | |
64 Neutral | ¥8.23B | 7.60 | ― | 1.90% | -0.17% | -37.01% | |
64 Neutral | ¥59.89B | 8.00 | ― | 2.67% | 6.26% | -11.38% | |
62 Neutral | ¥137.25B | 4.80 | 3.57% | 1.31% | 1.64% | -10.74% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | ¥34.67B | -9.37 | -0.13% | 2.31% | -10.04% | 43.13% | |
59 Neutral | ¥166.04B | 8.74 | 1.66% | 1.53% | -2.89% | -15.89% |